You've cut the soda, skipped the dessert, and your A1C still won't move. That's not a willpower problem — researchers now point to a hidden factor most diets never touch. The video below breaks down what it is and why cutting sugar alone was never going to be enough.
Research Shows
Left unmanaged, high blood sugar can progress toward nerve damage, vision loss, and even amputation.
It's a pattern researchers say affects nine out of ten people struggling to lower their A1C.
Research Reveals
A newly identified process now called Sugar Reset
Most researchers assumed a stubborn A1C came only from diet and insulin resistance.
Dr. William Lee found something different living inside pancreatic tissue — a parasite called Eurotrima pancreaticum. He noticed it showed up again and again in the hardest-to-lower cases.
A common prescription approach and other first-line treatments — the ones the $400 billion diabetes drug industry keeps prescribing — were never built to touch what lives inside the pancreas itself.
That may be why A1C numbers stall for years even when diet and exercise are followed perfectly. The longer it goes unaddressed, the harder those numbers seem to fight back.
For anyone who has tried to lower their A1C naturally and hit a wall, this finding changes the timeline.
Waiting on the same routine that has not moved the number in months is not a neutral choice.
What researchers are now calling the Sugar Reset — and what happens if it is left alone — is laid out in the presentation above.
Dr. Robert Schulman spent years validating standard protocols for patients struggling to lower their A1C. He dismissed the early data as noise, until colleagues pressed him to look closer himself. What he found changed how he talks about the diabetes drug industry in every interview since.
Research Shows
According to Dr. Robert Schulman, Metformin has been prescribed for 40 years as the first-line answer for rising A1C levels, long before questions were raised about how well it actually serves the patient. He points to newer injections, including A widely discussed prescription method and Mounjaro, now billed at roughly $1,500 a month to keep blood sugar in range. The health research is currently reviewing reports of serious considerations tied to those same injections.
Dr. Robert Schulman describes an industry that earns more every month a patient's numbers stay high, not lower.
Most people assume a stalled A1C means they simply need a stronger dose. Dr. Robert Schulman says the truth runs the opposite direction, and he lays it out in full during the interview.
You now know why the usual A1C fixes never touch what's actually driving the numbers.
The video shows exactly how the Sugar Reset works around it — something no prescription was ever built to do.
See the Sugar Reset Discovery Now